INVO Fertility, Inc. operates as a revenue-generating fertility business. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Follow-Up Questions
INVO Fertility Inc 'in CEO'su kimdir?
Mr. Steven Shum 2017 'den beri şirketle birlikte olan INVO Fertility Inc 'in Chief Executive Officer 'ıdır.
IVF hissesinin fiyat performansı nasıl?
IVF 'in mevcut fiyatı $0.8751 'dir, son işlem günde 0.71% decreased etti.
INVO Fertility Inc için ana iş temaları veya sektörler nelerdir?
INVO Fertility Inc Health Care endüstrisine ait ve sektör Health Care 'dir
INVO Fertility Inc 'in piyasa değerlemesi nedir?
INVO Fertility Inc 'in mevcut piyasa değerlemesi $3.8M 'dir
INVO Fertility Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 2 analist INVO Fertility Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 1 güçlü al, 3 al, 1 tut, 0 sat ve 1 güçlü sat içermektedir
